These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 11850844)

  • 1. Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St. John's wort that acts by induction of apoptosis.
    Schempp CM; Kirkin V; Simon-Haarhaus B; Kersten A; Kiss J; Termeer CC; Gilb B; Kaufmann T; Borner C; Sleeman JP; Simon JC
    Oncogene; 2002 Feb; 21(8):1242-50. PubMed ID: 11850844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines.
    Hostanska K; Reichling J; Bommer S; Weber M; Saller R
    Eur J Pharm Biopharm; 2003 Jul; 56(1):121-32. PubMed ID: 12837490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the St. John's wort constituent hyperforin on docetaxel metabolism by human hepatocyte cultures.
    Komoroski BJ; Parise RA; Egorin MJ; Strom SC; Venkataramanan R
    Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6972-9. PubMed ID: 16203790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
    Martínez-Poveda B; Quesada AR; Medina MA
    Int J Cancer; 2005 Dec; 117(5):775-80. PubMed ID: 15981212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional induction and de-induction of P-glycoprotein by St. John's wort and its ingredients in a human colon adenocarcinoma cell line.
    Tian R; Koyabu N; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Drug Metab Dispos; 2005 Apr; 33(4):547-54. PubMed ID: 15640377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo.
    Rothley M; Schmid A; Thiele W; Schacht V; Plaumann D; Gartner M; Yektaoglu A; Bruyère F; Noël A; Giannis A; Sleeman JP
    Int J Cancer; 2009 Jul; 125(1):34-42. PubMed ID: 19326439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous ethanolic extract of St. John's wort (Hypericum perforatum L.) induces growth inhibition and apoptosis in human malignant cells in vitro.
    Hostanska K; Reichling J; Bommer S; Weber M; Saller R
    Pharmazie; 2002 May; 57(5):323-31. PubMed ID: 12061257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of St. John's wort extract and its component hyperforin against cytokine-induced cytotoxicity in a pancreatic beta-cell line.
    Menegazzi M; Novelli M; Beffy P; D'Aleo V; Tedeschi E; Lupi R; Zoratti E; Marchetti P; Suzuki H; Masiello P
    Int J Biochem Cell Biol; 2008; 40(8):1509-21. PubMed ID: 18226577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aristoforin, a novel stable derivative of hyperforin, is a potent anticancer agent.
    Gartner M; Müller T; Simon JC; Giannis A; Sleeman JP
    Chembiochem; 2005 Jan; 6(1):171-7. PubMed ID: 15593112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway.
    Liu JY; Liu Z; Wang DM; Li MM; Wang SX; Wang R; Chen JP; Wang YF; Yang DP
    Chem Biol Interact; 2011 Apr; 190(2-3):91-101. PubMed ID: 21376709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual modulation of striatal acetylcholine release by hyperforin, a constituent of St. John's wort.
    Buchholzer ML; Dvorak C; Chatterjee SS; Klein J
    J Pharmacol Exp Ther; 2002 May; 301(2):714-9. PubMed ID: 11961077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA receptor-antagonistic properties of hyperforin, a constituent of St. John's Wort.
    Kumar V; Mdzinarishvili A; Kiewert C; Abbruscato T; Bickel U; van der Schyf CJ; Klein J
    J Pharmacol Sci; 2006 Sep; 102(1):47-54. PubMed ID: 16936454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: a possible role of hyperforin.
    Tadros MG; Mohamed MR; Youssef AM; Sabry GM; Sabry NA; Khalifa AE
    Behav Brain Res; 2009 May; 199(2):334-9. PubMed ID: 19136030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperforin, the active component of St. John's wort, induces IL-8 expression in human intestinal epithelial cells via a MAPK-dependent, NF-kappaB-independent pathway.
    Zhou C; Tabb MM; Sadatrafiei A; Grün F; Sun A; Blumberg B
    J Clin Immunol; 2004 Nov; 24(6):623-36. PubMed ID: 15622447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperforin and its analogues inhibit CYP3A4 enzyme activity.
    Lee JY; Duke RK; Tran VH; Hook JM; Duke CC
    Phytochemistry; 2006 Dec; 67(23):2550-60. PubMed ID: 17083953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of St John's wort (Hypericum perforatum L.) and of its metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
    Schempp CM; Winghofer B; Lüdtke R; Simon-Haarhaus B; Schöpf E; Simon JC
    Br J Dermatol; 2000 May; 142(5):979-84. PubMed ID: 10809859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures.
    Komoroski BJ; Zhang S; Cai H; Hutzler JM; Frye R; Tracy TS; Strom SC; Lehmann T; Ang CY; Cui YY; Venkataramanan R
    Drug Metab Dispos; 2004 May; 32(5):512-8. PubMed ID: 15100173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of β1 -adrenergic receptors in rat C6 glioblastoma cells by hyperforin and hyperoside from St John's wort.
    Jakobs D; Hage-Hülsmann A; Prenner L; Kolb C; Weiser D; Häberlein H
    J Pharm Pharmacol; 2013 Jun; 65(6):907-15. PubMed ID: 23647684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of mitochondrial permeability transition and cytochrome C release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells.
    Hirpara JL; Seyed MA; Loh KW; Dong H; Kini RM; Pervaiz S
    Blood; 2000 Mar; 95(5):1773-80. PubMed ID: 10688837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperforin--a key constituent of St. John's wort specifically activates TRPC6 channels.
    Leuner K; Kazanski V; Müller M; Essin K; Henke B; Gollasch M; Harteneck C; Müller WE
    FASEB J; 2007 Dec; 21(14):4101-11. PubMed ID: 17666455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.